Michael Goettler, Viatris CEO
October 12, 2022 02:22 PM EDT
Deals
Pharma

Vi­a­tris weighs sale of Eu­ro­pean con­sumer health busi­ness — re­port

Nicole DeFeudis

Editor

Fol­low­ing in the foot­steps of GSK and J&J, Vi­a­tris is re­port­ed­ly weigh­ing plans to ditch its con­sumer health as­sets.

Vi­a­tris is con­sid­er­ing a deal for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times